Skip to main navigation
CareDx
  • COMPANY
    • Management Team
    • Board of Directors
    • Compliance
    • Careers
      • Current Openings
      • Benefits
  • PRODUCTS
    • HeartCare, AlloMap
    • KidneyCare, AlloSure
    • Laboratory Products
    • Ottr
  • INVESTORS
  • CONTACT US

Press Releases

Media Inquiries - media@caredxinc.com
Date Title and Summary Additional Formats
Toggle Summary Jul 15, 2020 CareDx Chairman and CEO Peter Maag to Present at Global Kidney Innovations Summit
Peter Maag is Presenting on AI in Transplant Care at the AAKP and George Washington International Patient Summit SOUTH SAN FRANCISCO, Calif. , July 15, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and
View HTML
Toggle Summary Jun 22, 2020 New Kidney360 Publication Highlights CareDx’s AlloSure is Differentiated as the dd-cfDNA Test of Choice
Head to head data shows that not all dd-cfDNA is the same SOUTH SAN FRANCISCO, Calif. , June 22, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value
View HTML
Toggle Summary Jun 18, 2020 CareDx Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
SOUTH SAN FRANCISCO, Calif. , June 18, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today
View HTML
Toggle Summary Jun 18, 2020 FDA Accepts Letter of Intent for iBox Scoring System as a Surrogate Endpoint in Pharmaceutical Clinical Trials
CareDx congratulates C-Path’s Transplant Therapeutics Consortium on utilizing iBox to streamline the development of novel transplant drugs SOUTH SAN FRANCISCO, Calif. , June 18, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery,
View HTML
Toggle Summary Jun 15, 2020 CareDx Announces Closing of Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif. , June 15, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today
View HTML
Toggle Summary Jun 10, 2020 CareDx Announces Pricing of Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif. , June 10, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today
View HTML
Toggle Summary Jun 09, 2020 CareDx Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif. , June 09, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today
View HTML
Toggle Summary Jun 08, 2020 CareDx Announces 2020 Annual Meeting of Stockholders to be Held as a Virtual Meeting
SOUTH SAN FRANCISCO, Calif. , June 08, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today
View HTML
Toggle Summary Jun 04, 2020 CareDx to Participate at the Goldman Sachs Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif. , June 04, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today
View HTML
Toggle Summary May 28, 2020 CareDx to Present at the Jefferies Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif. , May 28, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today
View HTML

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • …
  • Next page Next
  • Last page Last
Displaying 31 - 40 of 285 results

Investor Relations

  • Investor Relations
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQs
  • Contact Us

Shareholder Tools

Printed Materials
E-mail Alerts
Downloads
RSS
Print
Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS

    ©2004-2017 CareDx, Inc. All Rights Reserved.    CareDx is a registered trademark of CareDx, Inc.

    Privacy & Compliance